Healthnostics Announces GMD Increases New Annualized Revenue by $1.2 Million Tuesday June 10, 9:45 am ET GMD, A National Consumer Diabetic Supply and Education Services Company Growing at Record Rate
NEW YORK--(BUSINESS WIRE)--Healthnostics, Inc. (Pink Sheets: HNSO - News), a medical and biotechnology information and technology company, previously announced that GMD Inc. (“GMD”) increased new patient customers by 30% in April, 2008 over the previous month. This equated to the addition of nearly 1,500 new covered lives.
This significant increase in new customers will produce nearly $1.2 million in new annualized revenue that is on a recurring basis. Healthnostics attributes this growth at GMD to a new marketing initiative that delivers pre-qualified diabetic patient leads in substantial numbers that were then converted and added to the GMD covered lives client base.
Alan Grofé, President of Healthnostics and CEO of GMD, Inc., commented, “I am pleased to be able to report this strong and continuing growth in annualized revenue. Additionally, we continue to project $10,000,000 in revenues for our fiscal year-end this month. Our future looks bright and I fully anticipate reporting strong sales and revenue growth for GMD in the future.”
About GMD, Inc.
Global Medical Direct is a nationwide Durable Medical Equipment provider specializing in direct to consumer diabetes supplies. The Company provides diabetes products and educational services to help patients lead healthier and more productive lives. The Company's products include blood glucose meters, test strips and ancillary supplies, insulin pumps and supplies, diabetes maintenance medications, diabetic shoes and orthopedic inserts.
This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management’s current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.
(HNSO) Healthnostics and GMD Addressing the Expanding $92 Billion Diabetic Supply Market)
NEW YORK, Jun 12, 2008 (BUSINESS WIRE) -- Healthnostics, Inc. (Pink Sheets: HNSO), a medical and biotechnology information and technology company, is leveraging their relationship with GMD Inc. ("GMD") to expand GMD's leading position in the growing diabetes supply market. Healthnostics and GMD believe that because the diabetic supply market is portioned into mostly small and medium-sized companies the opportunities for GMD's growth and consolidation opportunities abound.
GMD is currently positioned to take full advantage of the growing demand for accessible and well priced diabetic products and supplies, and expects with such an expanding market to increase revenues in the next fiscal year beginning July 1, 2008.
Currently there are $92 Billion in direct health costs associated with diabetes. 54 million Americans are pre-diabetic, with nearly 15 million diagnosed with diabetes and 1.5 million more diagnosed each year, according to the Centers for Disease Control (CDC). This epidemic increases the overall risk for death among people with diabetes to about 2 times that of people without diabetes. GMD is supplying the products and drugs required for these millions of diabetic patients to maintain control of this life-threatening disease.
"Healthnostics' and GMDs' management teams have the vision and experience to build a leading diabetic supply organization. Healthnostics brings the healthcare insight and development resources to GMD that can only help capitalize on the great start GMD has made in penetrating this growing market," said Alan Grofe, President of Healthnostics and CEO of GMD.
About GMD, Inc.
Global Medical Direct is a nationwide Durable Medical Equipment provider specializing in direct to consumer diabetes supplies. The Company provides diabetes products and educational services to help patients lead healthier and more productive lives. The Company's products include blood glucose meters, test strips and ancillary supplies, insulin pumps and supplies, diabetes maintenance medications, diabetic shoes and orthopedic inserts.
This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.
Junk stock continues to be junk...not sure why you keep pumping it.
Success is a State of Mind - - Tommy Bahama Profits always take care of themselves but losses never do. The speculator has to insure himself against considerable losses by taking their first small loss. - - Jesse Livermore The game of speculation is the most uniformly fascinating game in the world. But it is not a game for the stupid, the mentally lazy, the man of inferior emotional balance, nor for the get-rich-quick adventurer. They will die poor. - - Jesse Livermore
News for 'HNSO' - (Healthnostics Reports GMD, Inc. Maintains Record Revenue Pace for Fiscal Year Ending June 30, 2008 Audit Firm Search for GMD is Underway)
NEW YORK, Jun 16, 2008 (BUSINESS WIRE) -- Healthnostics, Inc. (OTC: HNSO), a medical and biotechnology information and technology company, is pleased to report that GMD Inc. ("GMD") has maintained its new revenue booking pace for a record year. GMD reports on a fiscal year basis with its current year end at June 30, 2008. $10,000,000 in revenue for this fiscal year was previously projected and announced.
Healthnostics has also begun interviewing audit firms for GMD that are qualified to issue reports for publicly-traded companies. Further information upon selection and engagement of an audit firm will be forthcoming.
Alan Grofe, President of Healthnostics and CEO of GMD, Inc., commented, "I continue to be encouraged by the growth, new marketing possibilities and prospects for GMD. We will continue to provide updates on new developments as they unfold."
About GMD, Inc.
Global Medical Direct is a nationwide Durable Medical Equipment provider specializing in direct to consumer diabetes supplies. The Company provides diabetes products and educational services to help patients lead healthier and more productive lives. The Company's products include blood glucose meters, test strips and ancillary supplies, insulin pumps and supplies, diabetic shoes and orthopedic inserts and diabetes maintenance medications.
This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.
Just a heads up people...I watch this company very closely as some of you know. I have noticed when they put out news, it's usually on a Tuesday. When there is a two PR week, it's usually issued on a Monday, like they did this week and then one Wednesday or Thursday. If you have been watching the volume, there was none today until just a little while ago. Now there is heavy buying which to me, suggest news is coming so...
HEADS UP PEOPLE!!!......This stock is junk and has started it's fall into oblivion. IMO...Lets see how the pumpers respond to this latest share price decline.
"A woman drove me to drink, and I didn't even have the decency to thank her." -- WC Fields
HEADS UP PEOPLE!!!......This stock is junk and has started it's fall into oblivion. IMO...Lets see how the pumpers respond to this latest share price decline.
Just wait until the filing comes out. What you are seeing is all MM manipulation, imo.
I see that you are still at it. HNSO is now down near it's low for the year at .0025. It traded at .024 in October. that is an 89.58% drop in eight months.
Since OS is close to 300M now and just say GMD had $500,000 net income(LOL)and HNSO owns 25% of GMD($2,250,000 annual gross or $125,000 of the net income), that comes out to negative on the annual eps. Now minus HNSOs costs from that....well you get the picture. JMO
Logged
Male
Not sure why the pump is still going.... 
